Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biomerica (BMRA) Other Operating Expenses (2020 - 2025)

Biomerica's Other Operating Expenses history spans 5 years, with the latest figure at $462000.0 for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 6.45% to $462000.0 in Q4 2025 year-over-year; TTM through Feb 2026 was $838000.0, a 69.78% decrease, with the full-year FY2025 number at $1.6 million, down 30.4% from a year prior.
  • Other Operating Expenses hit $462000.0 in Q4 2025 for Biomerica, up from $376000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for BMRA hit a ceiling of $2.3 million in Q2 2024 and a floor of -$456.0 in Q3 2021.
  • Historically, Other Operating Expenses has averaged $515802.1 across 4 years, with a median of $376000.0 in 2025.
  • Biggest five-year swings in Other Operating Expenses: crashed 100.32% in 2021 and later soared 415.15% in 2022.
  • Tracing BMRA's Other Operating Expenses over 4 years: stood at -$456.0 in 2021, then skyrocketed by 122.81% to $104.0 in 2022, then soared by 417207.69% to $434000.0 in 2024, then grew by 6.45% to $462000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for BMRA at $462000.0 in Q4 2025, $376000.0 in Q2 2025, and $434000.0 in Q4 2024.